SLC1A3 and glioblastoma: We used antibodies against Par3, NESTIN, CD133, and SOX2, which are established stem-cell markers in GBM, as well as GFAP and glutamate aspartate transporter (GLAST)-1, as indicators of the astrocytic lineage.